Skip to content Skip to footer
Udenyca: Benefits, Reviews, Info, Side Effects!
Rx Details
Udenyca
Pegfilgrastim, Neulasta, Fulphila
Pegfilgrastim
Prescription
Biosimilar
Drugs
Biosimilar
reduction in risk of infection, increase in white blood cell count, support for chemotherapy patients, decrease in duration of neutropenia
Bone Pain, Cough, Dizziness, Fatigue, Fever, Headache, Injection Site Reactions, Joint Pain, Muscle Pain, Nausea, Rash, Shortness Of Breath
Udenyca (pegfilgrastim-cbqv) is a biosimilar to Neulasta (pegfilgrastim) and is used to help reduce the risk of infection in patients undergoing chemotherapy by stimulating the production of white blood cells. The typical dosage for Udenyca is a single subcutaneous injection of 6 mg, administered once per chemotherapy cycle. It is usually given approximately 24 to 72 hours after the completion of chemotherapy. However, the exact dosage and timing should always be determined by a healthcare professional based on individual patient needs and treatment protocols.
Neutropenia
Similar safety profile to Neulasta
No Interactions Reported
$200 – $500
$3,000

A Synopsis of

Udenyca

Udenyca is a medication that belongs to a class of drugs known as granulocyte colony-stimulating factors (G-CSF). It is used to help stimulate the production of white blood cells in patients undergoing chemotherapy treatment. White blood cells are an essential part of the immune system and play a crucial role in fighting off infections.

One of the main benefits of Udenyca is its ability to reduce the risk of infection in patients receiving chemotherapy, which can weaken the immune system. By boosting the production of white blood cells, Udenyca helps to maintain a healthy immune system and reduce the likelihood of developing infections that could lead to serious complications.

Udenyca is typically administered as an injection under the skin, either by a healthcare professional or self-administered by the patient. It is important to follow the dosing instructions provided by your healthcare provider to ensure the medication is effective and safe.

Like all medications, Udenyca may cause side effects in some patients. Common side effects may include bone pain, muscle pain, headache, and fatigue. It is important to discuss any side effects with your healthcare provider to determine the best course of action.

Overall, Udenyca is a valuable medication for patients undergoing chemotherapy treatment. By helping to boost white blood cell production, it can reduce the risk of infections and improve overall outcomes for patients. If you have any questions or concerns about Udenyca, be sure to speak with your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN